Wanbury P/B Ratio
Wanbury P/B ratio. Wanbury (WANBURY) P/B ratio is 8.98 (High), book value per share ₹17.88 vs Healthcare average P/B of 0.01 — Very High - Significant premium, high growth expectations or speculative. Analyse WANBURY FII DII holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
Book Value Breakdown (2025)
Valuation Signal
Sector Context
WANBURY P/B Ratio — Valuation Insights & Book Value Analysis
Wanbury price-to-book ratio interpretation, valuation status and historical context — current P/B 8.98 (High). View WANBURY yearly price range for the annual high/low range and current price position.
- Stock appears overvalued with PB of 8.98, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 61.8% below historical average
- Trading at premium to sector average PB of 0.01
Wanbury P/B Ratio Historical Trend
WANBURY annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Wanbury share price screener.
WANBURY Historical P/B Ratio — Book Value Per Share & Year-End Price
Wanbury annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2025 | 12.67 | ₹17.88 | ₹226.60 | ₹59 | High |
| 2024 | 34.32 | ₹8.48 | ₹291.18 | ₹28 | High |
WANBURY vs Healthcare Peers — P/B Ratio Comparison
Wanbury P/B 8.98 vs Healthcare average 0.01, median 0.61 — range -6.55–1.13.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹35 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.8 | ₹147 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.19 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |